FDA Warning Letter — Abbott Diabetes Care, Inc.

Case 722046 — FEI 3002803444

The FDA took a Warning Letter action against Abbott Diabetes Care, Inc. on Jan 23, 2026 (Alameda, CA). The action was issued by CDRH and concerns devices products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Abbott Diabetes Care, Inc.
Date
Jan 23, 2026
Fiscal Year
2026
Product Type
Devices
Center
CDRH
Location
Alameda, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.